Nicholas Ostrout has been working in the advanced modality space for over a decade, with time spent at some of the leading companies in the space including Miltenyi Biotec, Lonza, and Charles River Labs. Dr. Ostrout has built numerous strategic partnerships with his time at these various companies that are still resulting in impacts being felt today, with several leading to muli-million dollars in revenue and milestones. Brining Wheeler and CRL together is just one example of many initiatives that Nick has led, but one in which he is extremely proud of, as he believes that Wheeler’s offering pairs perfectly with CRL services. The partnership further enhances CRL’s offering of its Concept to Cure portfolio across the advanced modality space, including cell and gene therapies.